Skin-tumor-initiating ability of benzo(a)pyrene-7,8-diol-9,10-epoxide (anti) when applied topically in tetrahydrofuran

The skin-tumor-initiating abilities of various metabolites of benzo(a)pyrene (BP) were determined in mice by using a two-stage system of tumorigenesis. We previously reported that BP-7,8-dihydrodiol (± trans) was approximately as potent as BP, suggesting that it may be a proximate carcinogen, but th...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 3; no. 1-2; pp. 23 - 30
Main Authors Slaga, Thomas J., Viaje, Aurora, Bracken, William M., Berry, David L., Fischer, Susan M., Miller, Don Ray, Leclerc, Susan M.
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 01.01.1977
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The skin-tumor-initiating abilities of various metabolites of benzo(a)pyrene (BP) were determined in mice by using a two-stage system of tumorigenesis. We previously reported that BP-7,8-dihydrodiol (± trans) was approximately as potent as BP, suggesting that it may be a proximate carcinogen, but the alleged ultimate carcinogen of BP [BP-7,8-dihydrodiol-9,10-epoxide (anti)] was a weak tumor initiator (Cancer Lett. 2: 115, 1976). Because of its high reactivity, the tumor-initiating ability of the BP-7,8-dihydrodiol-9,10-epoxide (anti) was determined by using acetone, benzene, and tetrahydrofuran (THF) as the solvent vehicles. The ‘diol-epoxide’ of BP was found to be an effective tumor initiator when applied topically in THF. The effectiveness of the various vehicles for the ‘diol-epoxide’ was as follows: THF > benzene > acetone; however, acetone was the best solvent for BP tumor initiation. The BP-9,10-dihydrodiol and BP-3-hydroxy were found to be weak tumor initiators. BP-3-hydroxy was also tested for tumor-promoting ability and was found to be inactive in this capacity.
ISSN:0304-3835
1872-7980
DOI:10.1016/S0304-3835(77)93845-9